Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,382 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase.
Kuznetsova I, Arnold T, Aschacher T, Schwager C, Hegedus B, Garay T, Stukova M, Pisareva M, Pleschka S, Bergmann M, Egorov A. Kuznetsova I, et al. Among authors: bergmann m. Mol Ther Oncolytics. 2017 Sep 8;7:37-44. doi: 10.1016/j.omto.2017.09.002. eCollection 2017 Dec 15. Mol Ther Oncolytics. 2017. PMID: 29034314 Free PMC article.
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine.
Romanova J, Krenn BM, Wolschek M, Ferko B, Romanovskaja-Romanko E, Morokutti A, Shurygina AP, Nakowitsch S, Ruthsatz T, Kiefmann B, König U, Bergmann M, Sachet M, Balasingam S, Mann A, Oxford J, Slais M, Kiselev O, Muster T, Egorov A. Romanova J, et al. Among authors: bergmann m. PLoS One. 2009 Jun 19;4(6):e5984. doi: 10.1371/journal.pone.0005984. PLoS One. 2009. PMID: 19543385 Free PMC article.
A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1.
Wacheck V, Egorov A, Groiss F, Pfeiffer A, Fuereder T, Hoeflmayer D, Kundi M, Popow-Kraupp T, Redlberger-Fritz M, Mueller CA, Cinatl J, Michaelis M, Geiler J, Bergmann M, Romanova J, Roethl E, Morokutti A, Wolschek M, Ferko B, Seipelt J, Dick-Gudenus R, Muster T. Wacheck V, et al. Among authors: bergmann m. J Infect Dis. 2010 Feb 1;201(3):354-62. doi: 10.1086/649428. J Infect Dis. 2010. PMID: 20039806 Clinical Trial.
Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer.
Arnold T, Michlmayr A, Baumann S, Burghuber C, Pluschnig U, Bartsch R, Steger G, Gnant M, Bergmann M, Bachleitner-Hofmann T, Oehler R. Arnold T, et al. Among authors: bergmann m. Eur J Clin Invest. 2013 Mar;43(3):286-91. doi: 10.1111/eci.12043. Epub 2013 Jan 25. Eur J Clin Invest. 2013. PMID: 23410002
IL-24 sensitizes tumor cells to TLR3-mediated apoptosis.
Weiss R, Sachet M, Zinngrebe J, Aschacher T, Krainer M, Hegedus B, Walczak H, Bergmann M. Weiss R, et al. Among authors: bergmann m. Cell Death Differ. 2013 Jun;20(6):823-33. doi: 10.1038/cdd.2013.15. Epub 2013 Mar 1. Cell Death Differ. 2013. PMID: 23449395 Free PMC article.
1,382 results